WO2005062991A3 - Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers - Google Patents

Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers Download PDF

Info

Publication number
WO2005062991A3
WO2005062991A3 PCT/US2004/043978 US2004043978W WO2005062991A3 WO 2005062991 A3 WO2005062991 A3 WO 2005062991A3 US 2004043978 W US2004043978 W US 2004043978W WO 2005062991 A3 WO2005062991 A3 WO 2005062991A3
Authority
WO
WIPO (PCT)
Prior art keywords
camptothecins
methods
treat cancers
esterification derivatives
derivatives
Prior art date
Application number
PCT/US2004/043978
Other languages
French (fr)
Other versions
WO2005062991A2 (en
Inventor
Zhi-Song Cao
Chunlin Tao
Original Assignee
American Bioscience Inc
Zhi-Song Cao
Chunlin Tao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Bioscience Inc, Zhi-Song Cao, Chunlin Tao filed Critical American Bioscience Inc
Publication of WO2005062991A2 publication Critical patent/WO2005062991A2/en
Publication of WO2005062991A3 publication Critical patent/WO2005062991A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention is related to lower alkyl 10,20 di-O-ester derivatives of camptothecins and pharmaceutical formulations thereof. The compounds and pharmaceutical formulations of the present invention possess increased biological life span and bioavailablity and reduced toxicity, while maintaining anti-cancer activity.
PCT/US2004/043978 2003-12-23 2004-12-23 Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers WO2005062991A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53194103P 2003-12-23 2003-12-23
US60/531,941 2003-12-23

Publications (2)

Publication Number Publication Date
WO2005062991A2 WO2005062991A2 (en) 2005-07-14
WO2005062991A3 true WO2005062991A3 (en) 2005-09-29

Family

ID=34738721

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/043978 WO2005062991A2 (en) 2003-12-23 2004-12-23 Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers

Country Status (1)

Country Link
WO (1) WO2005062991A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009001505A (en) 2006-08-11 2009-03-25 Christus Stehlin Foundation Fo Methods of making esters of camptothecins.
CN101402640B (en) * 2008-09-02 2011-06-15 暨南大学 Diester camptothecin derivative, preparation method and uses thereof
CN102895229A (en) * 2012-10-10 2013-01-30 中国药科大学 Medical application of camptothecin and its derivative in resisting Alzheimer disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407239B1 (en) * 1999-08-03 2002-06-18 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407239B1 (en) * 1999-08-03 2002-06-18 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers

Also Published As

Publication number Publication date
WO2005062991A2 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
WO2004108715A8 (en) 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
MXPA04005456A (en) Acetylene derivatives having mglur 5 antagonistic activity.
HK1088845A1 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
ATE463478T1 (en) DIARYL ETHER DERIVATIVE, ITS ADDITION SALT AND IMMUNOSUPPRESSANT
AU2003226572A1 (en) Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
WO2006050161A3 (en) Therapeutic furopyrimidines and thienopyrimidines
WO2004092135A3 (en) Substituted benzosulphonamide as potentiators of glutamate receptors
DK1725536T3 (en) Imidazoline derivatives with CB1 antagonistic activity
WO2006024486A3 (en) Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
BRPI0409611A (en) piperazine derivatives and their use for the treatment of neurological and psychiatric disorders
WO2003000699A8 (en) Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
MX2007000240A (en) Phenyl substituted [1.2]-oxazine-3,5-dione and dihydropyrone derivatives.
WO2004080922A3 (en) Substituted vitamin d analogues and their therapeutic uses
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
WO2004110990A3 (en) Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
WO2002024697A1 (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
WO2006110173A3 (en) Novel compounds
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
WO2004019879A3 (en) Motilide compounds
WO2003015780A3 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
WO2005062985A3 (en) Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
WO2005062991A3 (en) Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers
EP1661898A4 (en) Bicyclic piperazine compound and use thereof
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 28/2005 UNDER (81) ADD "SM"

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase